The authors discuss the preclinical evidence that provides insights into the mechanisms, pathways and mediators that set in motion resolution of inflammation. The time is ripe to establish if, and how, this biology can inform therapeutic innovation in the context of chronic inflammatory diseases.
- Mauro Perretti
- Dianne Cooper
- Lucy V. Norling